Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 41Carboplatin 32Gemcitabine 29Cyclophosphamide 29Cisplatin 25Biopsy 25Bevacizumab 24pembrolizumab 23Radiotherapy 22Paclitaxel 22Standard of Care 21Injections 21Drug Therapy 21Capecitabine 21fludarabine 20Oxaliplatin 20venetoclax 19Nivolumab 18toripalimab 17Interviews as Topic 17Dexamethasone 16Blood Specimen Collection 16tislelizumab 14Radiosurgery 14cemiplimab 13anlotinib 13Azacitidine 13Pemetrexed 12Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nephrectomy × 90 days × Clear all
NCT07516366 2026-05-15

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
16 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡